Piper Sandler raised the firm’s price target on CME Group to $240 from $225 and keeps an Overweight rating on the shares. Higher levels of equity market volatility produced a strong trading environment in Q3 and drove outperformance vs. the S&P 500 for every single Exchange stock in the firm’s coverage universe, Piper notes. Short-term upside might be limited at these levels, but the firm expects the Exchange & Trading companies to report solid Q3 results and continue benefiting from persistent volatility around the U.S. election season. And while lower rates create net interest income headwinds for eBrokers, Piper expects a more favorable retail trading environment and believes overall account growth will remain solid.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group downgraded to Neutral from Buy at Redburn Atlantic
- CME Group price target raised to $219 from $209 at Barclays
- CME Group price target raised to $250 from $240 at Citi
- CME Group price target raised to $180 from $177 at BofA
- CME Group price target raised to $198 from $195 at Goldman Sachs